137 related articles for article (PubMed ID: 37481366)
1. Corrigendum to "METTL3 enhances the stability of MALAT1 with the assistance of HuR via m6A modification and activates NF-κB to promote the malignant progression of IDH-wildtype glioma" [Canc. Lett. 511 (2021) 36-46].
Chang YZ; Chai RC; Pang B; Chang X; An SY; Zhang KN; Jiang T; Wang YZ
Cancer Lett; 2023 Aug; 569():216309. PubMed ID: 37481366
[No Abstract] [Full Text] [Related]
2. METTL3 enhances the stability of MALAT1 with the assistance of HuR via m6A modification and activates NF-κB to promote the malignant progression of IDH-wildtype glioma.
Chang YZ; Chai RC; Pang B; Chang X; An SY; Zhang KN; Jiang T; Wang YZ
Cancer Lett; 2021 Jul; 511():36-46. PubMed ID: 33933553
[TBL] [Abstract][Full Text] [Related]
3. The m6A methyltransferase METTL3 controls epithelial-mesenchymal transition, migration and invasion of breast cancer through the MALAT1/miR-26b/HMGA2 axis.
Zhao C; Ling X; Xia Y; Yan B; Guan Q
Cancer Cell Int; 2021 Aug; 21(1):441. PubMed ID: 34419065
[TBL] [Abstract][Full Text] [Related]
4. METTL3 enhances cell adhesion through stabilizing integrin β1 mRNA via an m6A-HuR-dependent mechanism in prostatic carcinoma.
Li E; Wei B; Wang X; Kang R
Am J Cancer Res; 2020; 10(3):1012-1025. PubMed ID: 32266107
[TBL] [Abstract][Full Text] [Related]
5. m
Jin D; Guo J; Wu Y; Du J; Yang L; Wang X; Di W; Hu B; An J; Kong L; Pan L; Su G
J Hematol Oncol; 2019 Dec; 12(1):135. PubMed ID: 31818312
[TBL] [Abstract][Full Text] [Related]
6. The m6A methyltransferase METTL3 cooperates with demethylase ALKBH5 to regulate osteogenic differentiation through NF-κB signaling.
Yu J; Shen L; Liu Y; Ming H; Zhu X; Chu M; Lin J
Mol Cell Biochem; 2020 Jan; 463(1-2):203-210. PubMed ID: 31643040
[TBL] [Abstract][Full Text] [Related]
7. METTL3 promote tumor proliferation of bladder cancer by accelerating pri-miR221/222 maturation in m6A-dependent manner.
Han J; Wang JZ; Yang X; Yu H; Zhou R; Lu HC; Yuan WB; Lu JC; Zhou ZJ; Lu Q; Wei JF; Yang H
Mol Cancer; 2019 Jun; 18(1):110. PubMed ID: 31228940
[TBL] [Abstract][Full Text] [Related]
8. Corrigendum to "Downregulation of MCT1 inhibits tumor growth, metastasis and enhances chemotherapeutic efficacy in osteosarcoma through regulation of the NF-κB pathway" [Canc. Lett. 342 (2014) 150-158].
Zhao Z; Wu MS; Zou C; Tang Q; Lu J; Liu D; Wu Y; Yin J; Xie X; Shen J; Kang T; Wang J
Cancer Lett; 2021 Dec; 522():281. PubMed ID: 34561145
[No Abstract] [Full Text] [Related]
9. Effect of m6A methyltransferase METTL3 -mediated MALAT1/E2F1/AGR2 axis on adriamycin resistance in breast cancer.
Li S; Jiang F; Chen F; Deng Y; Pan X
J Biochem Mol Toxicol; 2022 Jan; 36(1):e22922. PubMed ID: 34964205
[TBL] [Abstract][Full Text] [Related]
10. LncRNA MALAT1 regulates METTL3-mediated PD-L1 expression and immune infiltrates in pancreatic cancer.
Song Z; Wang X; Chen F; Chen Q; Liu W; Yang X; Zhu X; Liu X; Wang P
Front Oncol; 2022; 12():1004212. PubMed ID: 36212476
[TBL] [Abstract][Full Text] [Related]
11. The m6A methyltransferase METTL3 promotes LPS-induced microglia inflammation through TRAF6/NF-κB pathway.
Wen L; Sun W; Xia D; Wang Y; Li J; Yang S
Neuroreport; 2022 Apr; 33(6):243-251. PubMed ID: 33165191
[TBL] [Abstract][Full Text] [Related]
12. METTL3 modulates m6A modification of CDC25B and promotes head and neck squamous cell carcinoma malignant progression.
Guo YQ; Wang Q; Wang JG; Gu YJ; Song PP; Wang SY; Qian XY; Gao X
Exp Hematol Oncol; 2022 Mar; 11(1):14. PubMed ID: 35287752
[TBL] [Abstract][Full Text] [Related]
13. MTTL3 upregulates microRNA-1246 to promote occurrence and progression of NSCLC via targeting paternally expressed gene 3.
Huang S; Luo S; Gong C; Liang L; Xiao Y; Li M; He J
Mol Ther Nucleic Acids; 2021 Jun; 24():542-553. PubMed ID: 33898106
[TBL] [Abstract][Full Text] [Related]
14. m6A Methyltransferase METTL3 Reduces Hippocampal Neuron Apoptosis in a Mouse Model of Autism Through the MALAT1/SFRP2/Wnt/β-catenin Axis.
Ming Y; Deng Z; Tian X; Jia Y; Ning M; Cheng S
Psychiatry Investig; 2022 Oct; 19(10):771-787. PubMed ID: 36327957
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of the m6A Methyltransferase METTL3 Attenuates the Inflammatory Response in Fusarium solani-Induced Keratitis via the NF-κB Signaling Pathway.
Tang H; Huang L; Hu J
Invest Ophthalmol Vis Sci; 2022 Oct; 63(11):2. PubMed ID: 36194423
[TBL] [Abstract][Full Text] [Related]
16. METTL3-Mediated m
Mao Y; Li W; Weng Y; Hua B; Gu X; Lu C; Xu B; Xu H; Wang Z
Cell Transplant; 2022; 31():9636897221122997. PubMed ID: 36073002
[TBL] [Abstract][Full Text] [Related]
17. METTL3 enhances the effect of YTHDF1 on NEDD1 mRNA stability by m6A modification in diffuse large B-cell lymphoma cells.
Feng L; Yan Q; Pan H; Shi W
Immun Inflamm Dis; 2023 Feb; 11(2):e789. PubMed ID: 36840486
[TBL] [Abstract][Full Text] [Related]
18. Corrigendum: METTL3 contributes to osteosarcoma progression by increasing DANCR mRNA stability via m6A modification.
Zhou X; Yang Y; Li Y; Liang G; Kang D; Zhou B; Li Q
Front Cell Dev Biol; 2023; 11():1167476. PubMed ID: 37469575
[TBL] [Abstract][Full Text] [Related]
19. HBXIP drives metabolic reprogramming in hepatocellular carcinoma cells via METTL3-mediated m6A modification of HIF-1α.
Yang N; Wang T; Li Q; Han F; Wang Z; Zhu R; Zhou J
J Cell Physiol; 2021 May; 236(5):3863-3880. PubMed ID: 33305825
[TBL] [Abstract][Full Text] [Related]
20. METTL3 Contributes to Osteosarcoma Progression by Increasing DANCR mRNA Stability
Zhou X; Yang Y; Li Y; Liang G; Kang D; Zhou B; Li Q
Front Cell Dev Biol; 2021; 9():784719. PubMed ID: 35096816
[No Abstract] [Full Text] [Related]
[Next] [New Search]
